MRI of the Kidneys, Ureters, and Urinary Bladder


▪ Introduction

The tissue contrast and spectroscopic properties of magnetic resonance imaging (MRI) recommend its use as a problem solver for renal and urinary imaging. The unsurpassed ability to discriminate cystic from solid lesions and higher sensitivity to solid, neoplastic elements explains the superiority of MRI compared with other imaging modalities for imaging the kidney. Regarding the collecting system, ureters, and bladder, MRI features exquisite tissue contrast along with robust urographic effects because of the extreme 1) fluid hyperintensity in T2-weighted images and 2) the aramagnetism of excreted gadolinium in delayed postcontrast T1-weighted images. Typical indications for MR imaging of the kidneys, collecting systems, ureters, and bladder include indeterminate renal lesion, postsurgical and postablation follow-up of renal neoplasms, hematuria workup in patients unable to tolerate iodinated contrast, postnephroureterectomy surveillance following urothelial neoplasm resection, bladder carcinoma, pediatric and pregnancy conditions (in order to avoid iodinated contrast and/or ionizing radiation), and urinary obstruction not related to nephrolithiasis.

▪ Technique

Technical considerations in MR imaging of the kidneys are essentially the same as for other abdominal indications (see Chapter 1 ) with a few modifications. Subtracted images (precontrast from postcontrast) serve a central role in differentiating benign from malignant renal lesions. Certain common features—such as modest enhancement and precontrast T1 hyperintensity—challenge the human eye to detect or exclude enhancement. Subtractions eliminate precontrast hyperintensity and improve dynamic range to detect subtle enhancement.

The coronal plane is arguably more diagnostically compelling for the kidneys because of its superiority in displaying them bilaterally to assess symmetry. MR urography also favors the coronal plane because of the adaptability to the vertical orientation of the collecting system-ureter-bladder unit and the ability to portray bilaterality ( Fig. 6.1 ). As such, the MR urography protocol differs from the standard abdominal protocol (which typically suffices for nonurographic kidney indications) ( Table 6.1 ). Magnetic resonance urography (MRU) sequences include T1- and T2-weighted varieties. T1-weighted sequences are obtained after contrast, during the excretory phase, usually in the coronal plane as a modification of the dynamic sequence ( Fig. 6.1A ). 2-D and 3-D T2-weighted sequences are performed before contrast administration; otherwise, excreted gadolinium in the collecting systems shortens the T2 of urine, precluding signal in heavily T2-weighted images. The 2-D and 3-D MRU sequences are the magnetic resonance cholangiopancreatography (MRCP) sequences targeted to the collecting systems and ureters; instead of centering on the common bile duct, the slices are oriented to the renal collecting systems and ureters. Lasix administration (5–10 mg intravenously) augments collecting system distention, but presents logistical difficulties, especially in the outpatient setting.

▪ FIG. 6.1, Coronal MR urography. (A) Maximal intensity projection image from a delayed, T1-weighted, fat-suppressed postcontrast MRU sequence demonstrating the extreme contrast achieved by the urinary excretion of concentrated gadolinium. The left ureter is asymmetrically distended because of a distal ureteral stricture (arrow) . (B) The corresponding T2-weighted MRU sequence highlights the renal collecting system and ureters by exploiting the uniquely profoundly long T2 of free water protons compared with all other surrounding tissue in which essentially no residual transverse magnetization is available to contribute to signal because of the extremely high TE. However, the innumerable renal cysts also appear hyperintense, along with the cerebrospinal fluid, biliary system, and fluid in bowel loops.

TABLE 6.1
Magnetic Resonance Urography (MRU) Protocol
Sequence Plane Spatial Encoding Details
Steady-state Coronal or 3-plane 2-D T2/T1-weighted; balanced gradients in all axes ➔ insensitive to motion
Heavily T2-weighted Coronal 2-D Single-shot fast spin-echo technique
Heavily T2-weighted Axial 2-D Single-shot fast spin-echo technique; cover entire coil sensitivity range
In-/out-of-phase Axial 2-D Alternatively acquired as Dixon sequence
T2 MRU Radial 2-D Centered below each kidney; breathhold- or respiratory-triggered with delay between slices
T2 MRU Coronal 3-D Respiratory-triggered
T2 MRU Coronal 2-D Repeated eight times with delay between slices (cinegraphic effect)
Dynamic Axial 3-D Covering kidneys and below
Postcontrast Axial 3-D Covering pelvis
T1 MRU Coronal 3-D Covering kidneys, ureters, and bladder; first acquisition flip angle 15 degrees then repeat with 40 degrees
Diffusion Axial 2-D Covering kidneys through pelvis

Targeted bladder imaging (usually for bladder cancer evaluation and staging) requires targeted pelvic imaging focusing on T2-weighted imaging primarily and is supplemented by (dynamic) contrast-enhanced pulse sequences. T2-weighted images are performed with high-resolution technique with a time to echo (TE) in the 60 to 100 msec range in the sagittal and axial and/or coronal planes. The utility of dynamic imaging for bladder carcinoma has not been firmly established, but provides complementary information about both the bladder and surrounding structures.

▪ Interpretation

In the context of the kidneys, the first question to consider is whether the abnormality is a focal lesion or a diffuse process. Regarding focal lesions, the chief tissue considerations are: 1) whether a lesion is solid or cystic, 2) whether a solid lesion is a neoplasm or solid nonneoplastic tissue (ie, scar, infarct, or infection), 3) whether a solid lesion contains fat or not, 4) whether a fat-containing lesion contains microscopic/intracellular or macroscopic lipid, and 5) whether hemorrhage connotes an underlying lesion. Discriminating cystic from solid is straightforward and relies on T2-weighted images showing extreme fluid hyperintensity paired with a lack of enhancement. Difficulty in assessing enhancement arises in the case of the T1 hyperintense lesion (such as hemorrhagic cysts). Precontrast hyperintensity plus even more signal (from enhancement) is difficult for the human eye to detect. Subtracted images negate precontrast hyperintensity, showing only changes in signal intensity between the precontrast and the postcontrast image by literally subtracting the signal from each pixel in the precontrast image from each pixel in the postcontrast image. All that remains is a map of contrast enhancement (assuming no intervening patient motion causing misregistration). If subtractions are not available, comparing the region of interest (ROI) with a reference standard establishes or excludes enhancement. As a rule of thumb, normal muscle enhances and serves as a lower limit threshold for renal mass enhancement; most renal tumors enhance avidly, but relatively hypovascular papillary renal cell carcinomas tend to be relatively hypovascular. Compare the ROI signal intensity values of the pre- and postcontrast renal lesion with ROI values of normal muscle (eg, psoas, longissimus). An equal or greater increase compared with muscle indicates enhancement and solid tissue ( Fig. 6.2 ). Diffusion-weighted imaging provides another means of confirming solid tissue and restricted diffusion with lower ADC values compared with cystic lesions. Superimposed septations and mural nodularity or thickening potentially indicates a cystic neoplasm (which is relatively rare). Differentiating nonneoplastic solid lesions, such as scars, infarct, and pyelonephritis is more difficult and often relies on a combination of imaging features, clinical parameters, and longitudinal data (improvement or resolution versus growth).

▪ FIG. 6.2, Solid renal enhancement demonstrated using region of interest (ROI) measurements. ROIs placed over a large right renal lesion and left erector spinae muscles in the precontrast (A) and postcontrast (B) images reveal a much greater lesional increase in signal intensity (from 77.61–191.53 = 113.92) compared with muscle (from 88.57–94.64 = 6.07). (C) The corresponding subtracted image confirms avid enhancement. In a different patient with a small T2 hypointense right renal lesion ( arrow in D ), enhancement is questionable ( arrow in E ). Serial ROIs placed over the lesion and erector spinae muscles document relatively greater lesional signal change (from 33.36–47.27–54.79 = 21.43) compared with muscle (from 40.79–45.20–51.18 = 10.39), signaling mild enhancement—typical of papillary-type renal cell carcinoma (RCC) (subsequently confirmed at nephrectomy).

Identifying and characterizing fat in a solid renal lesion usually confer histopathologic diagnostic certainty and prognostic information. Microscopic fat with out-of-phase (OOP) signal loss generally connotes the clear cell histologic renal cell carcinoma (RCC) subtypes, although a very small fraction of lipid-poor angiomyolipomas (AMLs) shares this imaging pattern. Macroscopic fat appearing uniformly hyperintense and disappearing with fat suppression indicates a benign renal AML. The T1 hyperintensity of hemorrhage occasionally simulates macroscopic fat, but fails to suppress with fat saturation. Whereas RCC often harbors hemorrhage foci, renal or perinephric hemorrhage without an inciting incident (trauma, bleeding aneurysm, arteriovenous malformation, etc.) implies an underlying mass.

Dedicated bladder imaging requires high spatial resolution and bladder distention because the bladder wall is the focus of the examination and underdistention results in wall thickening and redundancy, simulating pathology. For the most part bladder imaging focuses on characterizing and staging bladder carcinoma, which requires an understanding of the normal mural stratification appearance of the pattern of tumor spread.

▪ Kidneys

Normal Features

Normal kidneys measure approximately 10 to 14 cm in length. Renal axes tilt medially at the upper poles with anteromedial rotation (according to the position of the hilum) and the kidneys extend from the T12–L1 to the L3 levels ( Fig. 6.3 ). The kidneys are cloaked in a sheath of retroperitoneal fat with interdigitating fibrous septa capped by the adrenal glands. A barely perceptible linear hypointensity encircles the retroperitoneal fat—Gerota’s fascia—an important landmark in staging RCC ( Box 6.1 ).

▪ FIG. 6.3, Normal kidneys and adrenal glands. Coronal T2-weighted images positioned through the posterior aspects (A) and midportions (B) of the kidneys show typical craniocaudal positioning and medial tilting. (C) The axial, fat-suppressed, T1-weighted image illustrates normal corticomedullary differentiation and orientation of the renal hila (arrows) .

BOX 6.1
Renal Cell Carcinoma (RCC) Staging

Primary Tumor (T)

T0: no evidence of primary tumor

T1: tumor ≤7 cm limited to kidney

T2: tumor >7 cm limited to kidney

T3: tumor extends into major veins; invades adrenal gland or perinephric tissues not beyond Gerota’s fascia

T3a: tumor invades adrenal gland or perinephric tissues not beyond Gerota’s fascia

T3b: tumor extends into major renal veins or IVC below diaphragm

T3c: tumor extends into major renal veins/IVC above diaphragm

T4: tumor invading beyond Gerota’s fascia

Regional Lymph Nodes (N)

N0: no regional lymph node metastasis

N1: metastasis in a single regional lymph node

N2: metastasis in >1 regional lymph node

Distant Metastasis (M)

M0: no distant metastasis

M1: distant metastasis

Robson Staging System

Stage I (T1 or 2, N0, M0): tumor confined to kidney

Stage II (T3a, N0, M0): tumor spread to perinephric fat confined with renal fascia; possible ipsilateral adrenal involvement

Stage IIIA (T3b–3c, N0, M0): tumor spread to renal vein, inferior vena cava or both

Stage IIIB (T1–T3a, N1–N3, M0): tumor spread to local lymph nodes

Stage IIIC (T3b–T3c, N1–N3, M0): tumor spread to local vessels and lymph nodes

Stage IVA (T4, any N, M0): tumor spread to adjacent organs (except ipsilateral adrenal gland)

Stage IVB (any T & N, M1): distant metastases

American Joint Committee on Cancer System

Stage I: T1, N0, M0

Stage II: T2, N0, M0

Stage III: T1–T2, N1, M0 or T3a-c, N0–N1, M0

Stage IV: T4 or any T, N2, M0 or any T, any N, M1

Normal kidneys exhibit corticomedullary differentiation characterized by moderately greater fluid content in the medulla, relative to the cortex ( Fig. 6.4 ). The kidneys enhance avidly with earlier enhancement of the renal cortex during the arterial phase, reiterating the corticomedullary pattern—the renal cortical phase for our purposes. Within 60 to 90 seconds contrast perfuses the medullary renal parenchyma, resulting in global renal parenchymal enhancement—the parenchymal phase.

▪ FIG. 6.4, T1-weighted image of the kidneys shows corticomedullary differentiation. The axial in-phase image (A) in a patient with normal renal function shows greater contrast between the hypointense renal medulla ( thin arrow in A ) and relatively hyperintense renal cortex ( thick arrow in A ), compared with the axial in-phase image (B) in a patient with severely depressed renal function (glomerular filtration rate 14).

The renal collecting system is generally biconcave or flat, and excreted urine demonstrates water signal. Occasional flow voids in T2-weighted images sometimes simulate renal calculi. The collecting system urothelial lining appears as inconspicuous linear hypointensity, exhibiting no discernible enhancement.

Anomalies and Pseudolesions

Congenital anomalies of the kidneys and urinary tract afflict 3 to 6 per 1000 live births, although only a few common developmental anomalies and pseudolesions ( Box 6.2 ) are worth mentioning before discussing pathologic renal lesions. Renal and collecting system embryogenesis is a complex process following a series of steps necessary for the execution of subsequent developmental steps. Incomplete or absent interfacing of the ureteric bud (primordial collecting system and ureter) and metanephric blastema (primordial renal parenchyma) results in renal agenesis and/or a number of other potential parenchymal and ureteral/collecting system anomalies.

BOX 6.2
Common Renal Developmental Anomalies and Pseudolesions

Inductional

Renal agenesis

Renal hypoplasia

Supernumerary kidney

Positional

Renal ectopia

Malrotation

Fusional

Horseshoe kidney

Crossed fused ectopia

Pancake kidney

Structural

Fetal lobulation

Prominent column of Bertin

Hilar lip

Positional anomalies include ectopia and malrotation. Embryonic growth results in a relative ascent of the kidneys during the fourth through eighth week of gestation, ultimately positioned between the first and third lumbar vertebrae. Underascent occurs far more commonly than overascent, and the ptotic kidney ranges in position from the true pelvis to the iliac fossa and anywhere below the expected location centered at the L2 level ( Fig. 6.5 ). Contralateral renal anomalies, such as renal agenesis or ptosis, frequently coexist.

▪ FIG. 6.5, Ptotic kidney. (A) The axial T2-weighted image through the upper abdomen shows a normal right kidney with no visible left kidney. (B) The steady-state coronal localizing image with a large field of view (FOV) shows a reniform structure in the pelvis (arrow) . The postcontrast coronal image (C) corroborates the presence of a pelvic kidney (arrow) , and the coronal maximal intensity projection image (D) illustrates the relative positioning and orientation of the left ( thin arrow in D ) and right ( thick arrow in D ) kidneys.

Concomitant medial rotation along the longitudinal renal axis, during ascent, orients the ureteropelvic junction (UPJ) medially. Nonrotation or incomplete rotation leaves the UPJ facing anteriorly, and renal calyces in the medial segment of the kidney lie medial to the renal pelvis ( Fig. 6.6 ). Overrotation results in a posteriorly facing UPJ.

▪ FIG. 6.6, Renal malrotation. Compare the orientation of the right renal hila in the steady-state images through the right renal hilum (A) and the left renal hilum (B) —note the underrotation of the left kidney reflected by the incomplete medial rotation. Normal renal rotation is approximately 30 degrees.

Renal fusion anomalies generally incur positional and rotational derangements. Medial renal fusion results in a solitary discoid lump of renal tissue in the pelvis, referred to as “pancake kidney.” Crossed fused renal ectopia represents the sequela of embryologic renal fusion with the relatively normally positioned kidney dragging its fused counterpart across the midline, resulting in a single ipsilateral S-shaped renal mass with two separate moieties and normal bilateral ureterovesical junctional positioning ( Fig. 6.7 ). Horseshoe kidney is the most common renal anomaly reflecting midline fusion of the metanephric blastema. Ascent is arrested at the level of the inferior mesenteric artery ( Fig. 6.8 ). Coexistent anomalies, such as UPJ obstruction and duplication anomalies, conspire with the geometric and rotational distortion and urinary stasis to lead to complications, including stone formation and infection.

▪ FIG. 6.7, Crossed fused renal ectopia. (A) Axial T2-weighted image through the upper abdomen reveals absence of the right kidney. (B) More caudally positioned axial T2-weighted image shows orientation of the left lower renal moiety (thin arrow) following the expected rotation of the right kidney with the hilum facing laterally (thick arrow) . (C) and (D) Coronal postcontrast images show the fused conglomerate renal mass with separate hilar structures (arrow) and disparate orientation.

▪ FIG. 6.8, Horseshoe kidney. (A) The axial T2-weighted image shows midline fusion of the lower renal poles (arrow) ventrally across the midline, anterior to the aorta. (B) The corresponding arterial phase postcontrast image depicts characteristic corticomedullary enhancement of the fused renal mass.

Structural anomalies incur no risk of complications and deserve mention only to prevent misdiagnosis. Fetal lobulation persists in 5% of adults with a smooth undulating outer renal contour conforming to the position of the renal pyramids. Smoothly marginated indentations conform to the edges of renal pyramids with normal appearance and thickness of underlying parenchyma (≥14 mm), excluding the possibility of an underlying mass or scarring. The column of Bertin potentially simulates a renal mass, but represents invagination of normal renal cortical tissue into the renal sinus, usually occurring at the upper polar/interpolar junction and averaging 3.5 cm in size ( Fig. 6.9 ). The hilar lip represents fusion of medial renal lobes, usually occurring in the upper pole and potentially protruding and distorting the renal sinus. Signal characteristics and enhancement identical to the adjacent renal parenchyma, occurring in the expected location, confirm the presence of normal functional renal tissue in cases of renal anomalies.

▪ FIG. 6.9, Column of Bertin. (A) The axial T2-weighted image illustrates protrusion of solid tissue isointense to surrounding normal renal parenchyma (arrow) and indenting the renal pelvis. (B) The finding (arrow) is more pronounced in the axial steady-state image. (C) The sagittal steady-state image portrays this finding as an isointensity (thin arrow) dividing the upper polar calyces (thick arrow) from the lower polar calyces (open arrow) . (D) The corresponding film from a retrograde pyelogram shows duplication of the renal collecting system, which is separated by the column of Bertin (arrow) .

Focal Lesions

Focal renal lesions are encountered every day in clinical practice in cross-sectional imaging studies—the vast majority of which are incidental, and many indeterminate. Thirteen percent to 27% of abdominal imaging studies incidentally detect a renal lesion. Whereas many of these lesions are incompletely characterized, the overwhelming majority of these lesions are simple or minimally complicated cysts with no malignant potential. Establishing true cystic etiology eliminates the need for further workup and/or follow-up. The presence of solid components implies malignancy, which usually mandates surgical resection ( Fig. 6.10 ).

▪ FIG. 6.10, Focal renal lesion algorithm.

Most renal cysts are simple in appearance with fluid signal characteristics (T2 hyperintensity and T1 hypointensity), no enhancement, septation, wall-thickening, or nodularity. However, simple cysts occasionally experience complications in the form of hemorrhage, infection, rupture, etc. As such, these benign, nonneoplastic cysts are referred to as “complicated cysts,” to distinguish them from complex/neoplastic cysts, which demonstrate some element of solid tissue. Signal alterations alone pose no risk of malignancy, although they often challenge interpretation. The most common signal alteration occurs as a result of hemorrhage, resulting in T1 hyperintensity and T2 hypointensity. Proteinaceous contents induce a similar appearance.

Other complicated cystic lesion features pose greater diagnostic difficulty. Superimposed infection and trauma induce reactive wall thickening, which overlaps with the appearance of cystic neoplasms (especially RCC, clear cell type). These neoplasms often harbor more complex features with mural nodularity and solid components. In an effort to stratify renal lesions based on the likelihood of malignancy, Bosniak developed a predictive classification system (for computed tomography [CT]) to guide management ( Table 6.2 ). Although not specifically adapted for MRI, this scheme illustrates the range of imaging complexity of renal lesions and offers management guidance. Although the MR inconspicuity of calcification precludes factoring it into the classification scheme, it generally applies to magnetic resonance (MR) findings—replacing intensity changes for density changes.

TABLE 6.2
Bosniak Classification Scheme for Cystic Renal Lesions
Bosniak Category Imaging Features Management
I Thin wall; no septa, calcifications, or solid components, water features; no enhancement No follow-up
II Few thin septa with less than or minimal enhancement; fine calcification or focal thick calcification; homogeneous high-density sharply marginated lesion (<3 cm) with no enhancement No follow-up
IIF Multiple thin septa with less than or minimal enhancement; thick or nodular calcification; no enhancing soft tissue components; high-density lesions (>3 cm) with no enhancement Observe
III Thickened irregular or smooth walls or septa with enhancement Surgery
IV Same features as III with enhancing soft tissue components Surgery

Solid lesions include benign and malignant neoplasms. Macroscopic fat is the only finding that connotes a benign etiology—AML. After excluding AML, renal infection and infarction, rare benign neoplasms (such as oncocytoma), and solid tissue (enhancement) effectively equals malignancy. Unless clinical findings raise the suspicion of inflammatory or vascular etiology, the presumptive diagnosis is malignancy until proved otherwise. Because biopsy results are notoriously confusing, solid renal lesion management involves either percutaneous ablation or surgical pathologic diagnosis and treatment. Because very small lesions (<1 cm) challenge the resolution of imaging methods, limiting diagnostic confidence, imaging surveillance preempts potentially unnecessary surgery ( Table 6.3 ).

TABLE 6.3
Management Scheme for Solid Renal Lesions
Size Presumptive Diagnosis Management
Large (>3 cm) Renal cell carcinoma (Partial) Nephrectomy
Small (1–3 cm) Renal cell carcinoma (Partial) Nephrectomy
Very small (<1 cm) Renal cell carcinoma, oncocytoma, angiomyolipoma Active surveillance

Ablative treatment is an option in the appropriate clinical setting.

Cystic Lesions

Using the combination of heavily T2-weighted images to detect fluid hyperintensity in postcontrast images to exclude enhancement confirms cystic etiology. T1-weighted sequences depict hemorrhagic cysts with variable hyperintensity, and postcontrast images exclude enhancement. Ninety percent of all renal cystic lesions are simple cysts ( Fig. 6.11 ). Hemorrhage, debris, and infection complicate renal cysts. If there is an increasing number of cystic lesions (and renal enlargement), consider the possibility of polycystic disease. Cystic lesions prevail in other inherited diseases, such as von Hippel–Lindau (VHL) disease and tuberous sclerosis (TS) (with assorted solid lesions, discussed in the section “Solid lesions with ball morphology”). Developmental etiologies include multicystic dysplastic kidney and calyceal diverticulum. Acquired conditions, such as renal cystic disease of dialysis and lithium therapy, present with renal cystic lesions. RCC (clear cell types) dominates the cystic neoplastic category; consider multilocular cystic nephroma (MLCN) in the appropriate demographic categories (young males and middle-aged females), with herniation into the renal pelvis.

▪ FIG. 6.11, Differential diagnosis of renal cystic lesions.

Simple Renal Cyst

The simple renal cyst is ubiquitous, with a prevalence of up to two thirds of the population, and increasingly prevalent with age. Renal cysts detach from the parent renal tubule and become self-enclosed; continued fluid secretion distends the cavity, resulting in an isolated cystic structure. Ongoing fluid secretion accounts for continued growth of simple renal cysts (≤5% per year), despite the lack of neoplastic or autonomously regenerating cells. Therefore careful attention to imaging features is paramount in excluding neoplasm.

The contents of the simple renal cyst—free water protons—account for its appearance: extreme T2 hyperintensity and T1 hypointensity with no enhancement. If even visible, the cyst wall is uniformly smooth with no perceptible enhancement in postcontrast images ( Fig. 6.12 ). Size varies from millimeters to over 10 cm. Cysts are stratified into three different categories based on their location: 1) exophytic, 2) parenchymal, and 3) parapelvic ( Figs. 6.13 and 6.14 ). Because most renal cysts arise from the cortex (although some develop from the medulla), most renal cysts are exophytic and/or intraparenchymal (see Figs. 6.12 and 6.13 ).

▪ FIG. 6.12, Simple renal cyst. A large, exophytic simple cyst (arrow) arising from the left kidney exhibits typical features—simple fluid T2 hyperintensity (A) and lack of enhancement (B) —based on the heavily T2-weighted (A) and the subtracted postcontrast (B) images. A comparison of the moderately T2-weighted fat-saturated (C) with the heavily T2-weighted (D) images in a different patient with a simple left renal cortical cyst (arrow) illustrates the effects of TE on free water (cyst) versus bound water (solid organs); free water maintains signal with increasing TE, whereas bound water loses signal. (E) The postcontrast image confirms absent enhancement (arrow) .

▪ FIG. 6.13, Renal cyst classification by location.

▪ FIG. 6.14, Parapelvic cysts. The coronal (A) and axial (B) heavily T2-weighted images show bilateral renal pelvic fluid signal intensity (arrows) potentially representing hydronephrosis. (C) The coronal postcontrast image obtained during the pyelographic phase excludes hydronephrosis by showing the normal-caliber collecting system (thin arrows) excreting contrast surrounded by the cystic hyperintensities—parapelvic cysts (thick arrows) .

Renal cyst complexity assumes many forms, which fall into two major categories—morphologic and signal-related. Morphologic derangements include deviation from simple sphericity and/or septation; signal derangements deviate from simple fluid characteristics with evidence of hemorrhage or debris ( Fig. 6.15 ). Occasional fluid-fluid levels depict layering hematocrit ( Fig. 6.16 )—a relatively infrequent manifestation of a hemorrhagic cyst. Signal alterations from hemorrhage present the greatest challenge to interpretation; precontrast hyperintensity limits the ability to detect augmented T1 signal from enhancement (see Fig. 6.15 ). Fibrinous septations from previous infection generally measure less than 2 mm in thickness with no other evidence of complexity to suggest neoplasm ( Fig. 6.17 ). As long as no enhancement beyond minimal linear septal or wall enhancement is present, simple cystic etiology is confirmed.

▪ FIG. 6.15, Hemorrhagic cyst with subtractions. Precontrast fat-suppressed image (A) shows an exophytic hyperintensity ( arrow in A ) protruding from the upper pole of the left kidney. No apparent change in signal intensity is evident after intravenous contrast ( arrow in B ), but subtle enhancement seems difficult to exclude. Subtracting the precontrast (A) from the postcontrast (B) image yields an enhancement map image—subtraction (C) —that depicts a signal void corresponding to the lesion (arrow) in question, excluding enhancement and confirming the diagnosis of a hemorrhagic cyst. (D) Another lesion (arrow) in the same patient exhibits modest T1 hyperintensity, which is more equivocal. The postcontrast image (E) suggests absent enhancement (arrow) , which is confirmed in the subtracted image (F) .

▪ FIG. 6.16, Hemorrhagic cyst with fluid-fluid level. (A) The T1-weighted out-of-phase image shows an exophytic lesion with a fluid-fluid level (arrow) arising from the left kidney. (B) Fat suppression improves the dynamic range, exaggerating the relative T1 hyperintensity, as seen in the precontrast, T1-weighted, fat-suppressed image. (C) T2-weighted fat-suppressed image, note the extreme T2 shortening of the layering blood products (arrow) in the hemorrhagic cyst.

▪ FIG. 6.17, Simple septated cyst. (A) An anterior partially exophytic cyst in the anterior interpolar left kidney (thin arrow) exhibits simple features, except for a thin, linear septum (thick arrow) in the heavily T2-weighted image. (B) No septal enhancement is apparent in the postcontrast image, confirming benign etiology (Bosniak II). (C) The coronal thick-slab magnetic resonance cholangiopancreatography (MRCP) image provides an overview of the septated renal cyst (thin arrow) and a contralateral septated cyst (thick arrow) .

Careful scrutiny of these features is critical, because a minority of clear cell RCC (less than 10%) is mostly cystic. In Bosniak’s terms, the discrimination of types II and IIF lesions from understated type III lesions bears close inspection. Usually, a solid enhancing component differentiates RCC from a nonneoplastic cyst—especially with the benefit of subtractions. When subtractions are not available and signal alterations limit assessment of enhancement, rely on ROI measurements compared with a reference standard (see Figs. 6.2 and 6.15 ). Other etiologies are not realistic considerations, except under specific circumstances. For instance, with multilocularity and when herniating into the renal pelvis, consider multilocular cystic nephroma (MLCN) in the appropriate demographic setting (young males or middle-aged females). Infectious cysts—renal abscesses and echinococcal cysts—require a suggestive history.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here